New York And Stockholm

Delcath Announces Further Results From Neuroendocrine Tumor Cohort Presented at European Multidisciplinary Cancer Congress

Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metastases in the Liver Presented at European Multidisciplinary Cancer Congress

First Line Achieves Premium Partner Status With EPiServer

NEW YORK and STOCKHOLM, September 25, 2011 - Delcath Systems (NASDAQ: DCTH) announced that James F.

NEW YORK and STOCKHOLM, September 23, 2011 - March 2011 Data Confirm Strong Treatment Effect of Chemosaturation Delcath Systems (NASDAQ: DCTH) announced today that James F.

MORE..

Older News

NEW YORK and STOCKHOLM, February 23, 2011 - First Line Software, a premiere provider of custom software development services, has been recognized as a Premium Partner by EPiServer AB, the world's fastest growing provider of Web Content Management (WCM) and online community platforms.

MORE..